Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2026-03-12 Share Issue/Capital Cha…
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - 4DX 7 pages 21.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities on the ASX. It includes information about securities issued due to options being exercised or convertible securities being converted, issue dates, number of securities, and issued capital following quotation. This is a formal announcement related to the listing or quotation of securities rather than a financial report, earnings release, or management discussion. The document is a regulatory announcement about capital changes and securities quotation, fitting the category of Share Issue/Capital Change filings.
2026-03-12 English
Application for quotation of securities - 4DX 7 pages 22.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and contains detailed information about securities issued, options exercised, and securities to be quoted on the ASX. It includes specifics about the number of securities, issue dates, and whether they are part of an employee incentive scheme. The document is an official application for quotation of securities following the exercise of options or conversion of convertible securities. This type of document is a formal announcement related to changes in the company's capital structure, specifically the quotation of new securities on the exchange. It does not contain financial statements, earnings data, or management discussion, nor is it a report or presentation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (9294 characters) is sufficient to be a full announcement rather than a brief notice or report publication announcement.
2026-03-03 English
Cleansing Notice 1 page 216.2KB
Share Issue/Capital Change Classification · 95% confidence The document is a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) related to the issue of shares by 4DMedical Limited. It details the issuance of shares on exercise of options and restricted stock units, compliance with relevant sections of the Corporations Act, and confirms no excluded information is present. The document is short (2089 characters) and serves as a regulatory announcement about a share issue without disclosure under Part 6D.2 of the Corporations Act. It is not a full financial report, earnings release, or detailed capital update but a formal notice related to share issuance compliance. This fits the category of Share Issue/Capital Change (SHA) announcements, which cover new share issues and related notices.
2026-03-03 English
Change of Director's Interest Notice GM & RF 5 pages 270.9KB
Director's Dealing Classification · 100% confidence The document is an Appendix 3Y filing, which is a Change of Director's Interest Notice pursuant to ASX Listing Rule 3.19A.2. It details the acquisition of shares by two directors through conversion of Restricted Stock Units. The document focuses on personal share transactions by company directors, disclosing changes in their shareholdings. There is no financial performance data, earnings information, or report publication. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 9320 characters, which is sufficient for a detailed notice but does not constitute a full financial report or announcement of a report publication. Therefore, the correct classification is Director's Dealing (DIRS).
2026-03-03 English
Appendix 4D and FY26 Half Year Report 28 pages 1.2MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-year Financial Report FY26' and references the half-year ended 31 December 2025, indicating it is a financial report for a period shorter than a full fiscal year. It includes detailed financial statements such as consolidated profit or loss, financial position, cash flows, notes to the financial statements, and an auditor's review report with a qualified opinion. The document also contains a Directors' report and detailed operational and financial review, which are typical components of an interim or quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual report, not just an announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2026
2026-02-26 English
Application for quotation of securities - 4DX 6 pages 18.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue dates, issue price, and the resulting issued capital. This type of filing is related to changes in the company's capital structure, specifically the issuance and quotation of new shares. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital change. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is the actual announcement, not just a notice or reference to another report.
2026-02-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.